Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Selective use of corifollitropin for controlled ovarian stimulation for IVF in patients with low anti-Müllerian hormone

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Low dose HP-hMG in an antagonist protocol for IVF in ovulatory and anovulatory patients with high AMH

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The impact of gastric bypass surgery on sex hormones and menstrual cycles in premenopausal women

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Atrial natriuretic peptide, copeptin and adrenomedullin levels in polycystic ovary syndrome: a case-control study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Left-right differences in ovarian volume and antral follicle count in 1423 women of reproductive age

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Endogenous thrombin potential in polycystic ovary syndrome: the association to body mass index, insulin resistance, and inflammation

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Recurrent pregnancy loss: couples' perspectives on their need for treatment, support and follow up

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cumulative live birth rate prognosis based on the number of aspirated oocytes in previous ART cycles

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. A randomized controlled trial of AMH-based individualized FSH dosing in a GnRH antagonist protocol for IVF

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Status one year after fertility assessment and counselling in women of reproductive age-a qualitative study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Corifollitropin, a long-acting follicle-stimulating hormone (FSH) analogue used for in vitro fertilization (IVF), does not allow individualization of dosage, and the ovarian response is similar to around 300 IU of daily recombinant FSH. This has raised concerns about the risk of ovarian hyperstimulation syndrome (OHSS) when used in standard patients. We administered corifollitropin selectively to patients with anticipated low to moderate ovarian response based on antimüllerian hormone levels in the lower quartile. The end points were oocyte distribution and occurrence of OHSS in women with AMH  ≤15 pmol/L. The study included a cohort of 368 patients treated in 599 cycles. Post hoc the cohort was subdivided according to AMH. With increasing baseline AMH, the number of oocytes increased from a mean of 2.7 (range 0-8 with AMH  <3 pmol/L) to 6.3 (range 0-15 with AMH 10-15 pmol/L) oocytes. Cancellations of retrievals and transfers decreased significantly with increasing AMH. Overall, the ongoing live pregnancy rate per started cycle was 15.2%. None developed OHSS. No cycles were cancelled or needed triggering of ovulation using a GnRH agonist due to risk of OHSS. Selective use of corifollitropin in patients with AMH in the lower quartile is a safe and appropriate way of optimising stimulation.

Original languageEnglish
JournalGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Volume32
Issue number8
Pages (from-to)625-28
DOIs
Publication statusPublished - 18 Feb 2016

ID: 46525015